2-脱氧-2,3-脱氢-N-乙酰神经氨酸衍生物对神经氨酸酶活性的抑制作用。 - Suppr

Suppr

超能文献

Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid.

作者信息

Meindl P, Bodo G, Palese P, Schulman J, Tuppy H

出版信息

Virology. 1974 Apr;58(2):457-63. doi: 10.1016/0042-6822(74)90080-4.

DOI:10.1016/0042-6822(74)90080-4

PMID:4362431

Abstract

摘要

相似文献

Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid.

Virology. 1974 Apr;58(2):457-63. doi: 10.1016/0042-6822(74)90080-4.

Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA).

Virology. 1974 Jun;59(2):490-8. doi: 10.1016/0042-6822(74)90458-9.

[Influence of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid on Myxovirus-neuraminidases and the replication of influenza- and Newcastle disease virus].

Z Naturforsch B. 1971 Aug;26(8):792-7. doi: 10.1515/znb-1971-0812.

On the inhibition mechanism of the sialidase activity from Newcastle disease virus.

Biol Chem Hoppe Seyler. 1991 Oct;372(10):923-7. doi: 10.1515/bchm3.1991.372.2.923.

Haemolysis by Sendai virus: lack of requirement for neuraminidase.

J Gen Virol. 1972 Aug;16(2):245-9. doi: 10.1099/0022-1317-16-2-245.

Isolation and purification of surface antigens from disrupted paramyxoviruses.

Med Microbiol Immunol. 1973 Sep 26;159(1):1-12. doi: 10.1007/BF02122645.

A comparison of "influenza C" with prototype myxoviruses: receptor-destroycing activity (neuraminidase) and structural polypeptides.

Virology. 1975 May;65(1):87-99. doi: 10.1016/0042-6822(75)90009-4.

Comparison of neuraminidases of paramyxoviruses with immunologically dissimilar hemagglutinins.

Virology. 1971 Dec;46(3):856-65. doi: 10.1016/0042-6822(71)90086-9.

Comparison of the neuraminidases of three avian paramyxoviruses.

Arch Gesamte Virusforsch. 1974;44(1):28-34. doi: 10.1007/BF01242178.

Mouse brain gangliosides. Their property of inhibiting EEE virus hemagglutination.

Arch Gesamte Virusforsch. 1973;43(3):184-90. doi: 10.1007/BF01250413.

引用本文的文献

Pharmacologic background and clinical issue of anti-influenza drugs.

Fukushima J Med Sci. 2025 Jan 18;71(1):1-12. doi: 10.5387/fms.24-00029. Epub 2024 Dec 18.

Retracted and republished from: "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs".

mBio. 2024 May 8;15(5):e0017524. doi: 10.1128/mbio.00175-24. Epub 2024 Mar 29.

Antiviral Approaches against Influenza Virus.

Clin Microbiol Rev. 2023 Mar 23;36(1):e0004022. doi: 10.1128/cmr.00040-22. Epub 2023 Jan 16.

Sialidase Inhibitors with Different Mechanisms.

J Med Chem. 2022 Oct 27;65(20):13574-13593. doi: 10.1021/acs.jmedchem.2c01258. Epub 2022 Oct 17.

Carbohydrate-based drugs launched during 20002021.

Acta Pharm Sin B. 2022 Oct;12(10):3783-3821. doi: 10.1016/j.apsb.2022.05.020. Epub 2022 May 23.

Influenza A Virus Neuraminidase Inhibitors.

Methods Mol Biol. 2022;2556:321-353. doi: 10.1007/978-1-0716-2635-1_21.

GANAB and -Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review.

Int J Mol Sci. 2022 Jul 1;23(13):7373. doi: 10.3390/ijms23137373.

Sialidase and Sialyltransferase Inhibitors: Targeting Pathogenicity and Disease.

Front Mol Biosci. 2021 Jul 29;8:705133. doi: 10.3389/fmolb.2021.705133. eCollection 2021.

Influenza Viruses: Harnessing the Crucial Role of the M2 Ion-Channel and Neuraminidase toward Inhibitor Design.

Molecules. 2021 Feb 7;26(4):880. doi: 10.3390/molecules26040880.

Intramolecular Lactones of Sialic Acids.

Int J Mol Sci. 2020 Oct 30;21(21):8098. doi: 10.3390/ijms21218098.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid.

作者信息

Meindl P, Bodo G, Palese P, Schulman J, Tuppy H

出版信息

Virology. 1974 Apr;58(2):457-63. doi: 10.1016/0042-6822(74)90080-4.

DOI:10.1016/0042-6822(74)90080-4

PMID:4362431

Abstract

摘要

相似文献

Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid.

Virology. 1974 Apr;58(2):457-63. doi: 10.1016/0042-6822(74)90080-4.

Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA).

Virology. 1974 Jun;59(2):490-8. doi: 10.1016/0042-6822(74)90458-9.

[Influence of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid on Myxovirus-neuraminidases and the replication of influenza- and Newcastle disease virus].

Z Naturforsch B. 1971 Aug;26(8):792-7. doi: 10.1515/znb-1971-0812.

On the inhibition mechanism of the sialidase activity from Newcastle disease virus.

Biol Chem Hoppe Seyler. 1991 Oct;372(10):923-7. doi: 10.1515/bchm3.1991.372.2.923.

Haemolysis by Sendai virus: lack of requirement for neuraminidase.

J Gen Virol. 1972 Aug;16(2):245-9. doi: 10.1099/0022-1317-16-2-245.

Isolation and purification of surface antigens from disrupted paramyxoviruses.

Med Microbiol Immunol. 1973 Sep 26;159(1):1-12. doi: 10.1007/BF02122645.

A comparison of "influenza C" with prototype myxoviruses: receptor-destroycing activity (neuraminidase) and structural polypeptides.

Virology. 1975 May;65(1):87-99. doi: 10.1016/0042-6822(75)90009-4.

Comparison of neuraminidases of paramyxoviruses with immunologically dissimilar hemagglutinins.

Virology. 1971 Dec;46(3):856-65. doi: 10.1016/0042-6822(71)90086-9.

Comparison of the neuraminidases of three avian paramyxoviruses.

Arch Gesamte Virusforsch. 1974;44(1):28-34. doi: 10.1007/BF01242178.

Mouse brain gangliosides. Their property of inhibiting EEE virus hemagglutination.

Arch Gesamte Virusforsch. 1973;43(3):184-90. doi: 10.1007/BF01250413.

引用本文的文献

Pharmacologic background and clinical issue of anti-influenza drugs.

Fukushima J Med Sci. 2025 Jan 18;71(1):1-12. doi: 10.5387/fms.24-00029. Epub 2024 Dec 18.

Retracted and republished from: "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs".

mBio. 2024 May 8;15(5):e0017524. doi: 10.1128/mbio.00175-24. Epub 2024 Mar 29.

Antiviral Approaches against Influenza Virus.

Clin Microbiol Rev. 2023 Mar 23;36(1):e0004022. doi: 10.1128/cmr.00040-22. Epub 2023 Jan 16.

Sialidase Inhibitors with Different Mechanisms.

J Med Chem. 2022 Oct 27;65(20):13574-13593. doi: 10.1021/acs.jmedchem.2c01258. Epub 2022 Oct 17.

Carbohydrate-based drugs launched during 20002021.

Acta Pharm Sin B. 2022 Oct;12(10):3783-3821. doi: 10.1016/j.apsb.2022.05.020. Epub 2022 May 23.

Influenza A Virus Neuraminidase Inhibitors.

Methods Mol Biol. 2022;2556:321-353. doi: 10.1007/978-1-0716-2635-1_21.

GANAB and -Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review.

Int J Mol Sci. 2022 Jul 1;23(13):7373. doi: 10.3390/ijms23137373.

Sialidase and Sialyltransferase Inhibitors: Targeting Pathogenicity and Disease.

Front Mol Biosci. 2021 Jul 29;8:705133. doi: 10.3389/fmolb.2021.705133. eCollection 2021.

Influenza Viruses: Harnessing the Crucial Role of the M2 Ion-Channel and Neuraminidase toward Inhibitor Design.

Molecules. 2021 Feb 7;26(4):880. doi: 10.3390/molecules26040880.

Intramolecular Lactones of Sialic Acids.

Int J Mol Sci. 2020 Oct 30;21(21):8098. doi: 10.3390/ijms21218098.